CRSP news

Latest 7 stories · newest Oct 19, 2026

CRSP
APP New CFO Andrew J. Silver Hired by CRISPR Therapeutics

CRISPR Therapeutics AG announced the hiring of Andrew J. Silver as its Chief Financial Officer. This leadership change is the primary market-relevant event from the filing.

CRSP
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
CRSP
Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among mRNA Names Trending Tonight
CRSP
Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why
CRSP
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
CRSP
CRISPR Q2 Revenue Rose 151% YoY As FDA Approved CASGEVY for Children Aged 2+

CRISPR Therapeutics reported strong second-quarter financial results with CASGEVY revenue rising 151% year-over-year. The FDA recently expanded CASGEVY approval to children as young as 2 years old, while the company initiated new Phase 1 trials for in vivo candidates CTX340 and CTX460.

CRSP
CRISPR Therapeutics files updated articles of association

CRISPR Therapeutics AG filed amended articles of association as Exhibit 3.1 to an 8-K filing, updating corporate governance documents. The filing is administrative in nature with no material operational or financial impact disclosed.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same CRSP feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/CRSP/newsSTART FREE